Login / Signup

Identification of Drug Combination Therapies for SARS-CoV-2: A Molecular Dynamics Simulations Approach.

Heba Abdel-HalimMalak HajarLuma HasounehSuzanne M A Abdelmalek
Published in: Drug design, development and therapy (2022)
was established in silico and in vitro assays. Molecular dynamics simulations showed promising results in predicting the synergistic effect of drug combinations.
Keyphrases
  • molecular dynamics simulations
  • molecular docking
  • sars cov
  • high throughput
  • adverse drug
  • respiratory syndrome coronavirus
  • drug induced
  • cancer therapy